4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-23-080099
Chief Medical Officer acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deliargyris Efthymios Chief Medical Officer | 2023-07-07 | Grant or award | +55,000 | 331,648 | D | ||
| Derivatives | |||||||
| Deliargyris Efthymios Chief Medical Officer | 2023-07-07 | Grant or award · Stock Option (right to buy) | +78,000 | 78,000 | D | ||
| Deliargyris Efthymios Chief Medical Officer | 2023-07-07 | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X04/tm2321021-1_4seq1.xml…